Daily non-political popular news in brief.

Effective HIV control may depend on viral protein targeted by immune cells

An effective response of the immune system's "killer" T cells against infection with HIV may depend on exactly which viral protein is targeted, according to an international group of researchers. A new study finds that HIV-infected individuals in whom virus-specific CD8 T cells are targeted against the Gag protein have lower viral levels than do those with CD8 responses directed against other viral proteins.

Read more »

Keywords: effective, hiv, control, depend, viral, protein, targeted, immune, cells, cell

« Previous | Next »

Similar news on "Effective HIV control may depend on viral protein targeted by immune cells":

1. Early-stage immune system control of HIV may depend on inherited factors
   11-03-2006 · EurekAlert!
   How well an individual's immune system controls HIV during the earliest phases of infection appears to depend on both the specific versions of key immune-system molecules called HLA Class I that have been inherited, as well as on the fragments of viral protein those molecules display to the T lymphocytes that usually destroy infected cells.
   Similar news · Read more »
   
2. Researchers discover new battleground for viruses and immune cells
   02-06-2008 · EurekAlert!
   Vaccines have led to many of the world's greatest public health triumphs, but many deadly viruses, such as HIV, still elude the best efforts of scientists to develop effective vaccines against them. An improved understanding of how the immune system operates during a viral infection is critical to designing successful anti-virus vaccines. Scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have added an important dimension to this knowledge.
   Similar news · Read more »
   
3. Novel vaccine concept developed by scientists at the Wistar Institute
   01-31-2008 · EurekAlert!
   A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
   Similar news · Read more »
   
4. Double trouble for RA patients: PLC-gamma-2 regulates osteoclastogenesis and B cell differentiation
   10-19-2006 · EurekAlert!
   Rheumatoid arthritis (RA) is caused by the immune system inappropriately attacking the joints. The autoimmune response also leads to the recruitment and/or differentiation of cells known as osteoclasts -- cells that degrade and resorb bone. Current treatments for RA target either the joint-specific immune response or the osteoclast-mediated bone erosion but a new study suggests that targeting a protein known as PLC-gamma-2 might lead to control of both immune-mediated joint destruction and osteoclast-mediated bone erosion.
   Similar news · Read more »
   
5. International HIV/AIDS trial finds risks increase on episodic antiretroviral therapy
   11-29-2006 · EurekAlert!
   Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV, to guide them in respectively suspending or restarting the study participants on antiretroviral therapy.
   Similar news · Read more »
   
6. An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
   10-08-2007 · EurekAlert!
   Researchers have shed new light on how Kaposi's Sarcoma-associated Herpes Virus subverts normal cell machinery to cause cancer. A KSHV protein called latency-associated nuclear antigen (LANA) helps the virus hide out from the immune system in infected cells. When LANA takes the place of other proteins that control cell growth, it can cause uncontrolled cell replication.
   Similar news · Read more »
   
7. Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily
   07-25-2007 · EurekAlert!
   Carnegie Mellon University scientists have made an important discovery that helps to explain why HIV enters immune cells with ease. They found that after HIV docks onto a host cell, it dramatically lowers the energy required for a cell membrane to bend, making it easier for the virus to infect immune cells. The finding will provide vital data to conduct future computer simulations of HIV dynamics to help further drug discovery and prevent deadly infections.
   Similar news · Read more »
   
8. Second pathway behind HIV-associated immune system dysfunction identified
   09-30-2007 · EurekAlert!
   Researchers at the Partners AIDS Research Center at Massachusetts General Hospital may have discovered a second molecular 'switch' that turns off the immune system's response against HIV. Last year the same team identified a molecule that suppresses the activity of HIV-specific CD8 T cells that should destroy virus-infected cells. Now they describe how a regulatory protein called CTLA-4 inhibits the action of HIV-specific CD4 T cells that control the overall response against the virus.
   Similar news · Read more »
   
9. Immune cells fighting chronic infections become progressively 'exhausted,' ineffective
   10-18-2007 · EurekAlert!
   A new study of immune cells battling a chronic viral infection shows that the cells, called T cells, become exhausted by the fight in specific ways, undergoing profound changes that make them progressively less effective over time. The findings also point to interventions that would reverse the changes, suggesting that novel therapies could be developed to reinvigorate T cells that become depleted in their struggle against a virus.
   Similar news · Read more »
   
10. A tricky tumor virus
    01-17-2008 · EurekAlert!
    Viruses use many tricks to gain control over their host cells and to reprogram them to their own advantage. Dr. Arnd Kieser and his colleagues of the Department of Gene Vectors of the Helmholtz Zentrum Munich, Germany, were able to show in a recent publication in PLoS Biology by which mechanism Epstein-Barr virus exploits a signal protein of its host cell, which normally mediates programmed cell death, in order to convert the cell into a cancer cell.
    Similar news · Read more »